Starbucks’ Schultz Announces Halt To Stock Repurchasing Program As He Returns

NEW YORK, April 4 (Reuters) – Starbucks Corp’s (SBUX.O) longtime former chief executive Howard Schultz announced on Monday the suspension of the company’s stock repurchasing program, as he returns this week to lead the global coffee chain for the third time. The suspension, effective immediately, will allow Starbucks to invest more in the company’s people and its…

Read More
Novartis Integrates Pharmaceuticals And Oncology, Targets Savings Of $1 Billion

Novartis Integrates Pharmaceuticals And Oncology, Targets Savings Of $1 Billion

ZURICH (Reuters) – Novartis said on Monday it was integrating its pharmaceuticals and oncology units into an innovative medicines (IM) business to simplify its structure, targeting savings of at least $1 billion by 2024. The Swiss pharmaceutical company said it expects value creation through these operational improvements, ensuring at least 4% sales growth and delivering…

Read More